Coagulation Modifier Drugs

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/21

flashcard set

Earn XP

Description and Tags

These flashcards cover key terms and definitions related to coagulation modifier drugs, hemostasis, and the mechanisms of action of different anticoagulants, antiplatelet agents, and thrombolytic drugs.

Last updated 7:22 PM on 10/19/25
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

22 Terms

1
New cards

Hemostasis

General term for any process that stops bleeding.

2
New cards

Thrombus

Technical term for a blood clot.

3
New cards

Embolus

Thrombus that moves through blood vessels.

4
New cards

Intrinsic pathway

One of the two pathways in the coagulation cascade that leads to clot formation.

5
New cards

Extrinsic pathway

The pathway activated by external trauma leading to rapid clot formation.

6
New cards

Fibrinolysis

Mechanism by which formed thrombi are lysed to prevent excessive clot formation.

7
New cards

Plasminogen

A circulating protein that binds to fibrin to form plasmin.

8
New cards

Plasmin

Enzymatic protein that breaks down fibrin thrombus.

9
New cards

Hemophilia

Rare genetic disorder resulting in limited or absent coagulation factors.

10
New cards

Anticoagulants

Substances that prevent or delay the coagulation of blood.

11
New cards

Thrombolytic drugs

Drugs that dissolve thrombi by functioning similar to tissue plasminogen activator.

12
New cards

Antiplatelet drugs

Substances that prevent platelet plugs from forming.

13
New cards

Hemorheologic drugs

Alter platelet function without preventing platelets from working.

14
New cards

Vitamin K-dependent clotting factors

Factors II, VII, IX, and X that require vitamin K for their synthesis.

15
New cards

Warfarin

An oral anticoagulant that inhibits vitamin K synthesis to prevent clot formation.

16
New cards

Low Molecular Weight Heparins (LMWHs)

Synthetic anticoagulants with more predictable responses than unfractionated heparin.

17
New cards

Heparin-induced thrombocytopenia (HIT)

A significant decrease in platelet count due to heparin therapy.

18
New cards

Idarucizumab (Praxbind)

Specific antidote for dabigatran.

19
New cards

Andexxa (Andexanet alfa)

Antidote for Factor Xa inhibitors to reverse anticoagulant effects.

20
New cards

Aspirin

An antiplatelet medication used to prevent thrombus formation.

21
New cards

Alteplase (Activase)

A thrombolytic drug specifically activating the fibrinolytic system.

22
New cards

Aminocaproic acid (Amicar)

An antifibrinolytic drug used to prevent excessive bleeding.